Ultra Vulgar Super Fiend

By Esteban

This was an article that I had set out to post about a month ago, and while not as topical as when these bills were put before the House, the War on Drugs still rages on and unless some earth shattering changes are made, prohibition will forever remain a hot button issue.

We like to joke about the recreational use of psychoactives here at UVSF as much as the next hangover-prone Angeleno, the truth of the matter is that our community endorses the legitimate scientific studies done behind emerging research chemicals including those produced by both David Nichols at Purdue University and independently by Dr. Alexander Shulgin.

While I admittedly have personally done advocacy work for LEAP and SSDP in the past, UVSF will not endorse any political party, alignment, or candidate. We strive to bring you objective news coverage of the issue you care about. With that in mind, we also endeavor to make scientific research chemical use a socially acceptable construct. This is a community where all intelligent minds and diverse opinions are welcome. Following are the bills that would potentially regulate these new drugs.

There are 3 other bills, 2 of which were pretty general (banning ephedrine and MDPV) which will likely die in committee. The wild card is S839 which aims to ban 9 of Shulginss creations in the 2C family. As this was proposed as a direct result of the deaths/hospitalizations in Minnesota attributed to 2c-e, it’s anybody’s guess whether this will pass, die, or get amended into HR1254/S605. Decide for yourself:

 

The front runners:

H.R. 1254: Synthetic Drug Control Act of 2011
Sponsor: Rep. Charles Dent [R-PA15]

3/30/2011–Introduced. Synthetic Drug Control Act of 2011 – Amends the Controlled Substances Act to add as schedule I controlled substances: (1) any material, compound, mixture, or preparation which contains cannabimimetic agents (or the salts, isomers, or salts of isomers thereof), including: -any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist -5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) -5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) -1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) -1-butyl-3-(1-naphthoyl)indole (JWH-073) -1-hexyl-3-(1-naphthoyl)indole (JWH-019) -1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) -1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250) -1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081) -1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) -1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) -1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) -1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) -1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4) -1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8) -1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203); and (2) the following hallucinogenic substances: -4-methylmethcathinone (Mephedrone) -3,4-methylenedioxypyrovalerone (MDPV) -3,4-methylenedioxymethcathinone (methylone) –Naphthylpyrovalerone (naphyrone) -4-fluoromethcathinone (flephedrone) -4-methoxymethcathinone (methedrone; Bk-PMMA) -Ethcathinone -3,4-methylenedioxyethcathinone (ethylone) -Beta-keto-N-methyl-3,4-benzodioxyolybutanamine (butylone) -N,N-dimethylcathinone (metamfepramone) -Alpha-pyrrolidinopropiophenone (alpha-PPP) -4-methoxy-alpha-pyrrolidinopropiophenone (MOPPP) -3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) -Alpha-pyrrolidinovalerophenone (alpha-PVP) -6,7-dihydro-5H-indeno(5,6-d)-1,3-dioxal-6-amine) (MDAI). Extends the period for which the Attorney General may temporarily schedule a substance in schedule I to avoid an imminent hazard to public safety to two years with a one-year extension (currently, one year with a six-month extension).

COMMENT: According to “The Hill”, a newspaper published for/about congress, this bill is expected to be voted on and passed by the House of Representatives this week (dec 05-dec 10, 2011

S. 605: Dangerous Synthetic Drug Control Act of 2011
A bill to amend the Controlled Substances Act to place synthetic drugs in Schedule I.
Sponsor: Sen. Charles Grassley [R-IA]
Introduced
Mar 17, 2011

Placed on Senate Calendar July 29, 2011

Dangerous Synthetic Drug Control Act of 2011 or David Mitchell Rozga Act – Amends the Controlled Substances Act to add as a schedule I controlled substance any material, compound, mixture, or preparation which contains cannabimimetic agents (or the salts, isomers, or salts of isomers thereof), including: -any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist; -5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497); -5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog); -1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678); -1-butyl-3-(1-naphthoyl)indole (JWH-073); -1-hexyl-3-(1-naphthoyl)indole (JWH-019); -1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200); -1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250); -1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081); -1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122); -1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398); -1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201); -1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694); -1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4); -1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8); -1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203) Extends the period during which the Attorney General may temporarily schedule a substance in schedule I to avoid an imminent hazard to public safety to two years with a one-year extension (currently, one year with a six-month extension).

Bills that will likely die

H.R. 1571: Combating Dangerous Synthetic Stimulants Act of 2011
Introduced in House April 15, 2011
Sponsor: Rep. Sandy Adams [R-FL24]

Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended in subsection (c) by adding at the end the following:‘(18) 4-methylmethcathinone (Mephedrone). ‘(19) 3,4-methylenedioxypyrovalerone (MDPV).’.

Jul 11, 2011: House Judiciary: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

COMMENT: My gut feeling is this one will die in committee as it looks like HR1254 will be passed instead.

S. 409: Combating Dangerous Synthetic Stimulants Act of 2011
Introduced Feb 17, 2011

A bill to ban the sale of certain synthetic drugs. Combating Dangerous Synthetic Stimulants Act of 2011 – Amends the Controlled Substances Act to include as a Schedule I controlled substance any material, compound, mixture, or preparation which contains 4-methylmethcathinone (Mephedrone) or 3,4-methylenedioxypyrovalerone (MDPV) or their salts, isomers, or salts of isomers.

Sponsor: Sen. Charles Schumer [D-NY]

The Wildcard:
S. 839: Combating Designer Drugs Act of 2011
A bill to ban the sale of certain synthetic drugs.
Sponsor: Sen. Amy Klobuchar [D-MN]
Introduced Apr 14, 2011
Placed on Senate Calendar July 28, 2011

Combating Designer Drugs Act of 2011 – Amends the Controlled Substances Act to include as a Schedule I controlled substance any material, compound, mixture, or preparation which contains: – 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E); – 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D); – 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C); – 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I); – 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2); – 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4); – 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H); – 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N); or – 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).

COMMENT: This appears to have been a direct result of the deaths in Minnesota allegedly related to 2C-E. There was no corresponding legislation introduced to the House of Representatives.

 

If you want to learn more about LEAP, check out this video: